Composition of Certain Financial Statement Captions (Tables)

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Composition of Certain Financial Statement Captions

(In thousands)	March 31, 2023		December 31, 2022
Accounts receivable, net:
Accounts receivable	$	123,553	$	131,474
Less: allowance for credit losses	(2,067)		(4,162)
	$	121,486	$	127,312
Inventories, net:
Consumable supplies	$	30,176	$	31,275
Finished products	39,260		37,139
Work in-process	2,897		2,449
Raw materials	7,671		6,771
Less: inventory reserve	(4,593)		(3,574)
	$	75,411	$	74,060
Other current assets and prepaid expenses:
Taxes recoverable	$	7,653	$	8,191
Prepaid expenses	9,058		7,918
Prepaid insurance	1,628		4,496
Other receivables	74,271		13,105
Other	6,081		6,252
	$	98,691	$	39,962
Intangible assets, net:
Customer relationships	$	315,586	$	314,854
Technologies	829,021		826,282
Trade names	49,767		49,752
Covenants not to compete	12,913		12,911
Licenses	6,100		5,988
Product registrations	7,176		6,831
Other	5,934		5,861
Less: accumulated amortization	(422,881)		(398,959)
	$	803,616	$	823,520
Accrued expenses:
Inventory received but not invoiced	$	7,830	$	7,830
Commitments and contingencies	4,006		4,295
Employee benefits	40,323		33,765
Clinical trials	5,708		4,700
Contingent consideration	65		62
Finance leases short-term	2,968		2,809
Professional fees	2,041		1,820
Other	43,117		42,988
	$	106,058	$	98,269
Other long-term liabilities:
Contingent consideration	$	1,114	$	974
Mortgages and other debts payable	8,801		9,098
Finance leases long-term	7,890		7,089
Contract liabilities	140		138
Other	10,035		10,072
	$	27,980	$	27,371

Schedule of Changes in Goodwill

The following table summarizes the changes in Goodwill by reporting unit during the three months ended March 31, 2023.

	2023
(In thousands)	Gross goodwill at January 1		Cumulative impairment at January 1		Acquisitions, dispositions and other		Foreign exchange and other		Balance at March 31
Pharmaceuticals
CURNA	$	4,827	$	(4,827)	$	—	$	—	$	—
Rayaldee	81,786		—		—		1,304		83,090
FineTech	11,698		(11,698)		—		—		—
ModeX	80,432		—		(173)		—		80,259
OPKO Biologics	139,784		—		—		—		139,784
OPKO Chile	3,767		—		—		284		4,051
OPKO Health Europe	7,057		—		—		114		7,171
OPKO Mexico	100		(100)		—		—		—
Transition Therapeutics	3,421		(3,421)		—		—		—
Diagnostics
BioReference	283,025		—		—		—		283,025
OPKO Diagnostics	17,977		(17,977)		—		—		—
	$	633,874	$	(38,023)	$	(173)	$	1,702	$	597,380